Assessment and Optimisation of Lung Cancer Patients for Treatment with Curative Intent.
View / Open Files
Authors
Harris, C
Meek, D
Gilligan, D
Williams, L
Solli, P
Rintoul, RC
Publication Date
2016-11Journal Title
Clinical Oncology
ISSN
1433-2981
Publisher
W. B. Saunders Co., Ltd.
Volume
28
Issue
11
Pages
682-694
Language
eng
Type
Article
This Version
AM
Metadata
Show full item recordCitation
Harris, C., Meek, D., Gilligan, D., Williams, L., Solli, P., & Rintoul, R. (2016). Assessment and Optimisation of Lung Cancer Patients for Treatment with Curative Intent.. Clinical Oncology, 28 (11), 682-694. https://doi.org/10.1016/j.clon.2016.08.002
Abstract
Over the past decade the field of lung cancer management has seen many developments. Coupled with an ageing population and increasing rates of comorbid illness, the work-up for treatments with curative intent has become more complex and detailed. As well as improvements in imaging and staging techniques, developments in both surgery and radiotherapy may now allow patients who would previously have been considered unfit or not appropriate for treatment with curative intent to undergo radical therapies. This overview will highlight published studies relating to investigation and staging techniques, together with assessments of fitness, with the aim of helping clinicians to determine the most appropriate treatments for each patient. We also highlight areas where further research may be required.
Keywords
Chemotherapy, fitness for surgery, lung cancer, lung function, radiotherapy, staging, Biomarkers, Tumor, Decision Making, Diagnostic Imaging, Humans, Lung Neoplasms
Sponsorship
Robert Rintoul is part funded by the National Institute for Health Research Cambridge Biomedical Research Centre and the Cambridge Cancer Centre.
Identifiers
External DOI: https://doi.org/10.1016/j.clon.2016.08.002
This record's URL: https://www.repository.cam.ac.uk/handle/1810/292113
Rights
Licence:
http://creativecommons.org/licenses/by-nc-nd/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.